Evidence map›Paper›PMID 36130928›Full record

ArticleCell death & disease2022

LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1/2.

Chia-Lang Hsu, Chieh-Fan Yin, Yi-Wen Chang, Ya-Chih Fan, Shih-Han Lin, Yu-Ching Wu, Hsuan-Cheng Huang, Hsueh-Fen Juan

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Computational and structural biotechnology journal · 2024
    Review
  9. Review
  10. Review
  11. WTAP-mediated mJournal of translational medicine · 2024
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chia-Lang Hsu *Department of Medical Research, National Taiwan University Hospital, Taipei, 100225, Taiwan.ORCID 0000-0002-7447-8045
Chieh-Fan Yin *Department of Life Science and Institute of Molecular and Cellular Biology, National Taiwan University, Taipei, 10617, Taiwan.
Yi-Wen ChangDepartment of Life Science and Institute of Molecular and Cellular Biology, National Taiwan University, Taipei, 10617, Taiwan.
Ya-Chih FanDepartment of Medical Research, National Taiwan University Hospital, Taipei, 100225, Taiwan.
Shih-Han LinDepartment of Life Science and Institute of Molecular and Cellular Biology, National Taiwan University, Taipei, 10617, Taiwan.
Yu-Ching WuDepartment of Medical Research, National Taiwan University Hospital, Taipei, 100225, Taiwan.
Hsuan-Cheng HuangInstitute of Biomedical Informatics, National Yang Ming Chao Tung University, Taipei, 112, Taiwan. hsuancheng@nycu.edu.tw.ORCID 0000-0002-3386-0934
Hsueh-Fen JuanCenter for Computational and Systems Biology, National Taiwan University, Taipei, 10617, Taiwan. yukijuan@ntu.edu.tw.ORCID 0000-0003-4876-3309
National Taiwan University · TWNational Taiwan University Hospital · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small nucleolar RNA host gene 1 (SNHG1) is a novel oncogenic long non-coding RNA (lncRNA) aberrantly expressed in different tumor types. We previously found highly expressed SNHG1 was associated with poor prognosis and MYCN status in neuroblastoma (NB). However, the molecular mechanisms of SNHG1 in NB are still unclear. Here, we disrupted endogenous SNHG1 in the MYCN-amplified NB cell line SK-N-BE(2)C using the CRISPR/Cas9 system and demonstrated the proliferation and colony formation ability of SNHG1-knowndown cells were suppressed. The transcriptome analysis and functional assays of SNHG1-knockdown cells revealed SNHG1 was involved in various biological processes including cell growth, migration, apoptosis, cell cycle, and reactive oxygen species (ROS). Interestingly, the expression of core regulatory circuitry (CRC) transcription factors in MYCN-amplified NB, including PHOX2B, HAND2, GATA3, ISL1, TBX1, and MYCN, were decreased in SNHG1-knockdown cells. The chromatin-immunoprecipitation sequencing (ChIP-seq) and transposase-accessible chromatin using sequencing (ATAC-seq) analyses showed that chromatin status of these CRC members was altered, which might stem from interactions between SNHG1 and HDAC1/2. These findings demonstrate that SNHG1 plays a crucial role in maintaining NB identity via chromatin regulation and reveal the function of the lncRNA SNHG1 in NB.

Indexed as

MicroRNAsNeuroblastomaRNA, Long NoncodingCell Line, TumorCell ProliferationChromatinGene Expression Regulation, NeoplasticHistone Deacetylase 1Histone Deacetylase 2HumansN-Myc Proto-Oncogene ProteinReactive Oxygen SpeciesRNA, Small NucleolarTransposasesChromatinHDAC1 protein, humanHDAC2 protein, humanHistone Deacetylase 1Histone Deacetylase 2MicroRNAsN-Myc Proto-Oncogene ProteinReactive Oxygen SpeciesRNA, Long NoncodingRNA, Small NucleolarTransposases

Identifiers

PMID36130928
PMCPMC9492769
OpenAlexW4296698992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.